BUPRENORPHINE - DEMONSTRATION OF PHYSICAL-DEPENDENCE LIABILITY

被引:65
作者
DUM, J [1 ]
BLASIG, J [1 ]
HERZ, A [1 ]
机构
[1] MAX PLANCK INST PSYCHIAT, DEPT NEUROPHARMACOL, KRAEPELINSTR 2, D-8000 MUNICH 40, GERMANY
关键词
D O I
10.1016/0014-2999(81)90163-1
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:293 / 300
页数:8
相关论文
共 14 条
[1]  
BLASIG J, 1973, PSYCHOPHARMACOLOGIA, V33, P19
[2]  
BRASE DA, 1976, J PHARMACOL EXP THER, V197, P317
[3]   AGONIST AND ANTAGONIST PROPERTIES OF BUPRENORPHINE, A NEW ANTINOCICEPTIVE AGENT [J].
COWAN, A ;
LEWIS, JW ;
MACFARLANE, IR .
BRITISH JOURNAL OF PHARMACOLOGY, 1977, 60 (04) :537-545
[4]  
COWAN A, 1974, ADV BIOCHEM PSYCHOPH, V8, P427
[5]   INVIVO OPIATE BINDING UNCHANGED IN TOLERANT-DEPENDENT MICE [J].
DUM, J ;
MEYER, G ;
HOLLT, V ;
HERZ, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1979, 58 (04) :453-460
[6]  
Gibson R D, 1970, J Pharm Sci, V59, P426, DOI 10.1002/jps.2600590338
[7]  
HOFFMEISTER F, 1972, SCHMERZ GRUNDLAGEN P, P290
[8]   MIXED AGONIST-ANTAGONIST OPIATES AND PHYSICAL-DEPENDENCE [J].
JACOB, JJC ;
MICHAUD, GM ;
TREMBLAY, EC .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 7 :S291-S296
[9]  
JASINSKI DR, 1978, ARCH GEN PSYCHIAT, V35, P501
[10]  
MARTIN WR, 1976, J PHARMACOL EXP THER, V197, P517